Assessment of acute lung injury/acute respiratory distress syndrome using B-type brain natriuretic peptide

Journal of International Medical Research

Volumn 43, Issue 6, 2015, Pages 802-808

  Sun, Yi zhu ^a   Gao, Yan ling ^a   Yu, Qing xia ^a   Wang, Jing ^a   Xia, Yong hon ^a   Lin, Hong yang ^a   Zhou, Shao ling ^a  

^a YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

acute respiratory distress syndrome; acute respiratory injury; B type natriuretic peptide; respiratory failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; OXYGEN;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTERIAL GAS; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; INVESTIGATIVE PROCEDURES; LUNG ALVEOLUS OXYGEN TENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; BLOOD; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ACUTE LUNG INJURY; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OXYGEN; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84949493467     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060515586245     Document Type: Article

References (24)

1. T.SudohK.KangawaN.Minamino. A new natriuretic peptide in porcine brain. Nature1988; 332: 78–81.
2. K.Dickstein. Natriuretic peptides in detection of heart failure. Lancet1998; 351: 4–4.
3. A.RaizadaS.BhandariM.A.Khan. Brain type natriuretic peptide (BNP) – a marker of new millennium in diagnosis of congestive heart failure. Indian J Clin Biochem2007; 22: 4–9.
4. R.JaraiJ.WojtaK.Huber. Circulation B-type natriuretic peptides in patients with acute coronary syndromes. Pathophysiological, prognostical and therapeutical considerations. Thromb Haemost2005; 94: 926–932.
5. S.VesconiG.P.RossiA.Pesenti. Pulmonary microthrombosis in severe adult respiratory distress syndrome. Crit Care Med1988; 16: 111–113.
6. G.R.BernardA.ArtigasK.L.Brigham. The American–European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med1994; 149: 818–824.
7. R.IrzmańskiL.PawlickiM.Charłusz. Concentration of natriuretic peptides in patients suffering from idiopathic arterial hypertension and left ventricular diastolic dysfunction confirmed by echocardiography. Clin Exp Hypertens2012; 34: 530–540.
8. M.F.SerondeE.GayatD.Logeart. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure. Int J Cardiol2013; 168: 3404–3411.
9. J.A.de LemosD.K.McGuireM.H.Drazner. B-type natriuretic peptide in cardiovascular disease. Lancet2003; 362: 316–322.
10. D.JeficJ.W.LeeD.Jefic. Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest2005; 128: 288–295.
11. F.AbrougL.Ouanes-BesbesN.Nciri. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med2006; 174: 990–996.
12. S.KrügerJ.GrafM.W.Merx. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J2004; 147: 60–65.
13. D.LogeartL.LecuyerG.Thabut. Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med2007; 33: 286–292.
14. C.PierrakosJ.L.Vincent. Sepsis biomarkers: a review. Crit Care2010; 14: R15–R15.
15. N.I.NikolaouC.GoritsasM.Dede. Brain natriuretic peptide increases in septic patients without severe sepsis or shock. Eur J Intern Med2007; 18: 535–541.
16. A.S.McLeanS.J.HuangS.Hyams. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med2007; 35: 1019–1026.
17. J.PapanikolaouD.MakrisD.Mpaka. New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care2014; 18: R94–R94.
18. D.J.SturgessT.H.MarwickC.Joyce. Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care2010; 14: R44–R44.
19. A.Mekontso-DessapN.de ProstE.Girou. B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med2006; 32: 1529–1536.
20. H.Ait-OufellaP.L.TharauxJ.L.Baudel. Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study. Intensive Care Med2007; 33: 1183–1186.
21. K.B.ShahM.M.NolanK.Rao. The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. Am J Med2007; 120: 1071–1077.
22. D.KarmpaliotisA.J.KirtaneC.P.Ruisi. Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest2007; 131: 964–971.
23. D.OsakaY.ShibataK.Kanouchi. Soluble endothelial selectin in acute lung injury complicated by severe pneumonia. Int J Med Sci2011; 8: 302–308.
24. J.PhuaT.K.LimK.H.Lee. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med2005; 33: 2094–2013.